Skip to main content
S

Swish30

Swish30 provides nutraceutical manufacturers and supplement formulators with ultra‑fine, water‑encapsulated ingredients that achieve higher cellular absorption.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Many dietary supplement ingredients consist of large molecular structures that are poorly absorbed by human cells, leading to low bioavailability and wasted dosage.

Solution

Swish30 applies its proprietary HydraStat™ delivery technology to reduce supplement molecules to ultrafine particles and encapsulate them within ultra‑pure water clusters. This process breaks down large compounds, creating particles small enough for efficient cellular uptake. The resulting ingredients exhibit higher absorption rates and consistent third‑party tested purity, delivering more effective supplementation without increasing dosage.

Target Audience

Primary customers are nutraceutical manufacturers, supplement formulators, and health‑product distributors seeking higher‑bioavailability ingredients for their product lines.

Features

  • Ultrasonic or high‑shear processing that fragments supplement molecules to nanoscale dimensions
  • Encapsulation of ultrafine particles in ultra‑pure water clusters to stabilize and protect active compounds
  • HydraStat™ platform that enhances solubility and cellular permeability across a broad range of nutraceuticals
  • Third‑party batch testing for potency, purity, and contaminant levels to ensure quality compliance
  • Scalable manufacturing workflow compatible with standard supplement ingredient production lines
This profile is AI-generated and may contain inaccuracies.